Literature DB >> 30442697

Toward Better Understanding of Flow Diversion in Bifurcation Aneurysms.

M Shapiro1,2, A Shapiro3, E Raz4, T Becske5, H Riina2,6, P K Nelson4,6.   

Abstract

BACKGROUND AND
PURPOSE: Flow diversion is being increasingly used to treat bifurcation aneurysms. Empiric approaches have generally led to encouraging results, and a growing body of animal and ex vivo literature addresses the fate of target aneurysms and covered branches. Our prior investigations highlighted the dynamic nature of metal coverage provided by the Pipeline Embolization Device and suggested strategies for creating optimal single and multidevice constructs. We now address the geometric and hemodynamic aspects of jailing branch vessels and neighboring target aneurysms.
MATERIALS AND METHODS: Fundamental electric and fluid dynamics principles were applied to generate equations describing the relationships between changes in flow and the degree of vessel coverage in settings of variable collateral support to the jailed territory. Given the high complexity of baseline and posttreatment fluid dynamics, in vivo, we studied a simplified hypothetic system with minimum assumptions to generate the most conservative outcomes.
RESULTS: In the acute setting, Pipeline Embolization Devices modify flow in covered branches, principally dependent on the amount of coverage, the efficiency of collateral support, and intrinsic resistance of the covered parenchymal territory. Up to 30% metal coverage of any branch territory is very likely to be well-tolerated regardless of device or artery size or the availability of immediate collateral support, provided, however, that no acute thrombus forms to further reduce jailed territory perfusion.
CONCLUSIONS: Basic hemodynamic principles support the safety of branch coverage during aneurysm treatment with the Pipeline Embolization Device. Rational strategies to build bifurcation constructs are feasible.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 30442697      PMCID: PMC7655381          DOI: 10.3174/ajnr.A5874

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

Review 1.  Computational fluid dynamics in brain aneurysms.

Authors:  Daniel M Sforza; Christopher M Putman; Juan R Cebral
Journal:  Int J Numer Method Biomed Eng       Date:  2011-11-28       Impact factor: 2.747

2.  The varying porosity of braided self-expanding stents and flow diverters: an experimental study.

Authors:  A Makoyeva; F Bing; T E Darsaut; I Salazkin; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-09       Impact factor: 3.825

3.  Building multidevice pipeline constructs of favorable metal coverage: a practical guide.

Authors:  M Shapiro; E Raz; T Becske; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-27       Impact factor: 3.825

4.  Quantitation of carotid stenosis with continuous-wave (C-W) Doppler ultrasound.

Authors:  M P Spencer; J M Reid
Journal:  Stroke       Date:  1979 May-Jun       Impact factor: 7.914

5.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

6.  Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.

Authors:  Tibor Becske; David F Kallmes; Isil Saatci; Cameron G McDougall; István Szikora; Giuseppe Lanzino; Christopher J Moran; Henry H Woo; Demetrius K Lopes; Aaron L Berez; Daniel J Cher; Adnan H Siddiqui; Elad I Levy; Felipe C Albuquerque; David J Fiorella; Zsolt Berentei; Miklós Marosfoi; Saruhan H Cekirge; Peter K Nelson
Journal:  Radiology       Date:  2013-02-15       Impact factor: 11.105

7.  Metal coverage ratio of pipeline embolization device for treatment of unruptured aneurysms: Reality check.

Authors:  Liang-Der Jou; Gouthami Chintalapani; Michel E Mawad
Journal:  Interv Neuroradiol       Date:  2015-11-30       Impact factor: 1.610

8.  Anterior choroidal artery patency and clinical follow-up after coverage with the pipeline embolization device.

Authors:  E Raz; M Shapiro; T Becske; D W Zumofen; O Tanweer; M B Potts; H A Riina; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-08       Impact factor: 3.825

9.  Flow-Diverter Stents for the Treatment of Saccular Middle Cerebral Artery Bifurcation Aneurysms.

Authors:  J Caroff; H Neki; C Mihalea; F D'Argento; H Abdel Khalek; L Ikka; J Moret; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

10.  Patency of the posterior communicating artery after flow diversion treatment of internal carotid artery aneurysms.

Authors:  Waleed Brinjikji; Giuseppe Lanzino; Harry J Cloft; David F Kallmes
Journal:  Clin Neurol Neurosurg       Date:  2014-03-03       Impact factor: 1.876

View more
  3 in total

1.  Longitudinal Monitoring of Flow-Diverting Stent Tissue Coverage After Implant in a Bifurcation Model Using Neurovascular High-Frequency Optical Coherence Tomography.

Authors:  Jildaz Caroff; Robert M King; Giovanni J Ughi; Miklos Marosfoi; Erin T Langan; Christopher Raskett; Ajit S Puri; Matthew J Gounis
Journal:  Neurosurgery       Date:  2020-11-16       Impact factor: 4.654

2.  Complex Wide-necked and Lobulated Aneurysm of the Middle Cerebral Artery Bifurcation : Treatment with a pCONUS2 Neck Bridging Device and p48MW Flow Modulation Device.

Authors:  Alexander Sirakov; Marta Aguilar-Perez; Muhammad AlMatter; Hans Henkes
Journal:  Clin Neuroradiol       Date:  2019-12-05       Impact factor: 3.649

3.  Expanding Indications for Flow Diverters: Distal Aneurysms, Bifurcation Aneurysms, Small Aneurysms, Previously Coiled Aneurysms and Clipped Aneurysms, and Carotid Cavernous Fistulas.

Authors:  Nicola Limbucci; Giuseppe Leone; Leonardo Renieri; Sergio Nappini; Federico Cagnazzo; Antonio Laiso; Mario Muto; Salvatore Mangiafico
Journal:  Neurosurgery       Date:  2020-01-01       Impact factor: 4.654

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.